News Digest / Ticker: SRRK

Ticker: SRRK

08:09am, Wednesday, Aug 06, 2025

Scholar Rock Appoints New CEO, Faces Financial Challenges Despite Promising Drug Trial Results

Company: Scholar Rock Holding Corporation (NASDAQ: SRRK) Recent Developments: In April 2025, David Hallal was appointed CEO following Jay T. Backstrom's transition to Senior Advisor. Scholar Rock announced positive top-line data from the Phase 2 EMBRAZE trial evaluating apitegromab for preservin...

08:02am, Wednesday, May 14, 2025

Scholar Rock Advances with Positive Trial Results as Financial Losses Surge in Q1 2025